Frohlich, Joel http://orcid.org/0000-0001-8382-4344
Chiang, Jeffrey N.
Mediano, Pedro A. M. http://orcid.org/0000-0003-1789-5894
Nespeca, Mark
Saravanapandian, Vidya
Toker, Daniel
Dell’Italia, John
Hipp, Joerg F.
Jeste, Shafali S.
Chu, Catherine J.
Bird, Lynne M. http://orcid.org/0000-0003-4833-3747
Monti, Martin M. http://orcid.org/0000-0001-5511-3780
Article History
Received: 26 July 2022
Accepted: 1 December 2022
First Online: 15 December 2022
Change Date: 10 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-023-04418-9
Change Date: 13 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-023-04460-7
Competing interests
: J.F. is a former employee of F. Hoffmann-La Roche Ltd. (October 2016–July 2017). J.F.H. is a current employee of F. Hoffmann-La Roche Ltd. C.J.C. consults for Biogen Inc and Ovid Pharmaceuticals. The remaining authors declare no competing interests.